Product Images Isosorbide Dinitrate And Hydralazine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Isosorbide Dinitrate And Hydralazine Hydrochloride NDC 52536-006 by Wilshire Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text describes figure 1 which is a Kaplan-Meier Plot of Time to Death by All Cause in Black Patients (A-HeFT). It shows a 43% reduction in mortality between BiDil and Placebo. The P-value is 0.012 assessed by Log-Rank Test. The text also includes a time scale, 0-600 days, and multiple numerical values.*
The text describes a Kaplan-Meier plot showing the time to first hospitalization for heart failure in black patients. The plot indicates a 39% risk reduction in the first hospitalization for heart failure between patients who took H compared to those who took a placebo. There is also a p-value of less than 0.001. The plot contains details such as time in days and the number of patients at risk over time.*
This is a medication label for Isosorbide Dinitrate and Hydralazine HCI tablets with a strength of 0mg/30mg. The tablets come in a bottle with 90 tablets and the National Drug Code (NDC) is 52536-006-09. The medication should be stored at room temperature within the range of 15°C - 30°C (59°F - 86°F). This medication requires a prescription and the label includes a revision date of 01/21. The last phrase is not readable and appears to be in a non-English language.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.